| Autor: |
Abrahamson MJ, Comi RJ, Glaser V |
| Zdroj: |
Patient Care (Print); Feb2005, Vol. 39 Issue 2, p55-64, 7p |
| Abstrakt: |
The glycosylated hemoglobin (HbA1C) level is the best available indicator of blood glucose control in patients with diabetes.Target goals for HbA1C range from 6.5% to 7.0%, and as low as 6.0% in individual patients.Reducing elevated HbA1 C levels has a positive impact on risk of microvascular diabetes complications and may also reduce the risk of cardiovascular events and mortality from cardiovascular disease.Only about 37% of people with diagnosed diabetes have an HbA1C level less than 7.0%.Glycemic goals in diabetes are not pursued aggressively enough by physicians or patients.A team approach to diabetes management works best; diet and nutritional counseling are essential for achieving glycemic goals.Aggressive prescribing of oral medications or insulin for type 2 diabetes should begin before the HbA1C rises above recommended levels. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
